Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2016, Article ID 9469276, 17 pages
http://dx.doi.org/10.1155/2016/9469276
Review Article

Chinese Herbal Medicine as an Adjunctive Therapy for Breast Cancer: A Systematic Review and Meta-Analysis

Center of Reproductive Medicine and Traditional Chinese Medicine Constitution, School of Preclinical Medicine, Beijing University of Chinese Medicine, Beijing 100029, China

Received 6 February 2016; Accepted 16 March 2016

Academic Editor: Oliver Micke

Copyright © 2016 Libing Zhu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. M. Parkin, “Global cancer statistics in the year 2000,” The Lancet Oncology, vol. 2, no. 9, pp. 533–543, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. R. L. Siegel, K. D. Miller, and A. Jemal, “Cancer statistics, 2016,” CA: A Cancer Journal for Clinicians, vol. 66, no. 1, pp. 7–30, 2016. View at Publisher · View at Google Scholar
  3. C. Sotiriou, S.-Y. Neo, L. M. McShane et al., “Breast cancer classification and prognosis based on gene expression profiles from a population-based study,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 18, pp. 10393–10398, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Sørlie, C. M. Perou, R. Tibshirani et al., “Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 19, pp. 10869–10874, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. Y. Cui, X.-O. Shu, Y. Gao et al., “Use of complementary and alternative medicine by Chinese women with breast cancer,” Breast Cancer Research and Treatment, vol. 85, no. 3, pp. 263–270, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. J. J. Tao, K. Visvanathan, and A. C. Wolff, “Long term side effects of adjuvant chemotherapy in patients with early breast cancer,” The Breast, vol. 24, supplement 2, pp. S149–S153, 2015. View at Publisher · View at Google Scholar
  7. A. M. Gonzalez-Angulo, F. Morales-Vasquez, and G. N. Hortobagyi, “Overview of resistance to systemic therapy in patients with breast cancer,” Advances in Experimental Medicine and Biology, vol. 608, pp. 1–22, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Molassiotis, J. A. Scott, N. Kearney et al., “Complementary and alternative medicine use in breast cancer patients in Europe,” Supportive Care in Cancer, vol. 14, no. 3, pp. 260–267, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Molassiotis, P. Fernandez-Ortega, D. Pud et al., “Use of complementary and alternative medicine in cancer patients: a European survey,” Annals of Oncology, vol. 16, no. 4, pp. 655–663, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Shen, R. Andersen, P. S. Albert et al., “Use of complementary/alternative therapies by women with advanced-stage breast cancer,” BMC Complementary and Alternative Medicine, vol. 2, article 8, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. L. M. DiGianni, J. E. Garber, and E. P. Winer, “Complementary and alternative medicine use among women with breast cancer,” Journal of Clinical Oncology, vol. 20, no. 18, supplement, pp. 34s–38s, 2002. View at Google Scholar · View at Scopus
  12. J. Huebner, K. Muenstedt, F. J. Prott et al., “Online survey of patients with breast cancer on complementary and alternative medicine,” Breast Care, vol. 9, no. 1, pp. 60–63, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Sparber, L. Bauer, G. Curt et al., “Use of complementary medicine by adult patients participating in cancer clinical trials,” Oncology Nursing Forum, vol. 27, no. 4, pp. 623–630, 2000. View at Google Scholar · View at Scopus
  14. Z. Chen, K. Gu, Y. Zheng, W. Zheng, W. Lu, and X. O. Shu, “The use of complementary and alternative medicine among Chinese women with breast cancer,” Journal of Alternative and Complementary Medicine, vol. 14, no. 8, pp. 1049–1055, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. W. C. S. Cho, “Scientific evidence on the supportive cancer care with chinese medicine,” Chinese Journal of Lung Cancer, vol. 13, no. 3, pp. 190–194, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. Q. T. Chen, H. X. Zhu, Z. Q. Liu, H. B. Wang, Y. Xu, and Y. Li, “Clinical observation on the effect-enhancing and toxicity-reducing efficacy of Dangguibuxue decoction for postoperative breast cancer patients with chemotoxicity,” Journal of Hebei Medical College for Continuing Education, no. 6, pp. 50–51, 2008. View at Google Scholar
  17. Y. Q. Liang, W. J. Yin, W. Qian, H. L. Wang, C. Ma, and H. Y. Du, “Effects of Huaier Granule combined with systemic chemotherapy on immunologic function and prognosis for advanced breast cancer patients,” Chinese Journal of Bases and Clinics in General Surgery, no. 12, pp. 1482–1486, 2015. View at Google Scholar
  18. Y. L. Du, Z. M. Wang, F. Wang, and D. Y. Lu, “Efficacy observation on modified Xiaoyao powder combined with chemotherapy for postoperative breast cancer,” Modern Journal of Integrated Traditional Chinese Medicine and Western Medicine, no. 3, pp. 295–297, 2015. View at Google Scholar
  19. A. B. Miller, B. Hoogstraten, M. Staquet, and A. Winkler, “Reporting results of cancer treatment,” Cancer, vol. 47, no. 1, pp. 207–214, 1981. View at Publisher · View at Google Scholar · View at Scopus
  20. L. L. D. Zhong, H.-Y. Chen, W. C. S. Cho, X.-M. Meng, and Y. Tong, “The efficacy of Chinese herbal medicine as an adjunctive therapy for colorectal cancer: a systematic review and meta-analysis,” Complementary Therapies in Medicine, vol. 20, no. 4, pp. 240–252, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. WHO, WHO Handbook for Reporting Results of Cancer Treatment, World Health Organization, Geneva, Switzerland, 1979.
  22. J. Higgins and S. Green, Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0, 2016.
  23. J. P. T. Higgins and S. Green, Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0, 2011.
  24. H. W. Li, “Self-made Fuzheng Xiaoliufang as an adjuvant therapy for advanced breast cancer and its impact on serum tumor marker,” China Pharmaceuticals, no. 3, pp. 11–13, 2015. View at Google Scholar
  25. H. H. Chen, W. Wang, G. X. Shi, and J. W. Li, “Effect of Chinese herbal compound combining chemotherapy on recurrence breast cancer,” Liaoning Journal of Traditional Chinese Medicine, no. 5, pp. 1003–1005, 2015. View at Google Scholar
  26. J. G. Wang, “The long-term efficacy observation on Xiaozheng compound as an adjuvant therapy for breast cancer liver metastasis,” Journal of New Chinese Medicine, no. 6, pp. 224–225, 2015. View at Google Scholar
  27. L. L. Fang and Y. Jia, “Method of promoting blood circulation to remove blood stasis and detoxication combined with chemotherapy on breast cancer of intermediate stage and advanced stage,” Journal of Shanxi College of Traditional Chinese Medicine, no. 2, pp. 52–53, 2015. View at Google Scholar
  28. J. W. Bai and W. M. Wu, “Efficacy analysis of Jin Long Capsule (JLC) in neoadjuvant chemotherapy of breast cancer,” Chinese Journal of Clinical Oncology, no. 4, pp. 246–249, 2014. View at Google Scholar
  29. L. Guo, “Experience of 76 cases with mammary cancer treated with integrated Chinese and western medicine,” Clinical Journal of Chinese Medicine, no. 15, pp. 137–138, 2014. View at Google Scholar
  30. F. Xie, “Clinical analysis Shenqifuzheng injection combined with chemotherpay in the treatment of breast cancer,” Guide of China Medicine, no. 30, pp. 19–20, 2014. View at Google Scholar
  31. J. Yang, J. L. He, X. X. Li, and Y. H. Yang, “Analysis of curative effect of spleen and kidney strengthening herb combined with observation of 43 cases,” Guiding Journal of Traditional Chinese Medicine and Pharmacy, no. 13, pp. 33–35, 2014. View at Google Scholar
  32. Y. S. Cheng, F. Y. Gong, A. W. Li, Y. S. Wen, G. J. Wang, and Y. Lv, “Modified Lizhong decoction for nausea and vomiting caused by breast cancer chemotherapy,” Journal of Sichuan of Traditional Chinese Medicine, no. 5, pp. 90–91, 2013. View at Google Scholar
  33. D. J. Wang, “Clinical observation of Chinese and Western drugs for the treatment of 76 cases of breast cancer,” Medical Recapitulate, vol. 14, pp. 2676–2678, 2013. View at Google Scholar
  34. L. K. Xiong, “The impact of Fuzheng Xiaoji compound combined with chemotherapy on the quality of life and serum tumor marker of breast cancer patients,” Yunnan Journal of Traditional Chinese Medicine, no. 4, pp. 14–15, 2012. View at Google Scholar
  35. S. X. Zhang and H. Dang, “The method of Fuzheng Guben combined with NP chemotherapy for 30 cases advanced breast cancer,” Guangming Journal of Chinese Medicine, no. 5, pp. 980–982, 2012. View at Google Scholar
  36. L. M. Pan, “Cinobufagin combined with chemotherapy for 160 cases advanced breast cancer,” China Foreign Medical Treatment, no. 1, pp. 59–61, 2011. View at Google Scholar
  37. G. W. Yang, “Combination of the magical power of trichosanthes and chemotherapy in advanced breast cancer,” Journal of Liaoning University of TCM, no. 7, pp. 84–85, 2011. View at Google Scholar
  38. Y. Cheng, “Clinical observation on Fuzheng Kanai compound combined TP for advanced breast cancer,” Medical Technology, no. 12, pp. 92–93, 2011. View at Google Scholar
  39. Y. C. Zhang, X. J. Li, Y. J. Jia, J. Chen, and Y. Y. Sun, “Clinical observation of ‘Fuzheng Quyu Jiedu Prescription’ combining with chemotherapy in treating postoperative breast cancer,” Shanghai Journal of Traditional Chinese Medicine, no. 11, pp. 64–66, 2011. View at Google Scholar
  40. J. J. Feng, J. P. Zhao, W. K. Jia, G. Y. Zhao, and T. Peng, “Effect observation of chemotherapy with modified Wumeiwan on advanced breast cancer,” Shanxi Journal of Traditional Chinese Medicine, no. 7, pp. 33–34, 2010. View at Google Scholar
  41. P. Y. Zhang, “Chinese herbal compound combined with chemotherapy for 50 cases advanced breast cancer,” Liaoning Journal of Traditional Chinese Medicine, no. 4, pp. 130–131, 2009. View at Google Scholar
  42. G. W. Yang, Y. M. Xu, Q. Fu et al., “Clinical observat ion on guben Yiliu II combined with chemotherapy in the treatment of 28 cases of advanced breast cancer,” Journal of Traditional Chinese Medicine, no. 12, pp. 1081–1083, 2008. View at Google Scholar
  43. J. H. Hu, Y. F. Yuan, and J. Q. He, “Yiqihuoxue decoction combined with new adjuvant chemotherapy for 28 cases breast cancer,” Hunan Journal of Traditional Chinese Medicine, no. 2, pp. 38–39, 2008. View at Google Scholar
  44. J. W. Tang, L. Li, and X. Y. Tang, “Yiqijiedu decoction combined with chemotherapy for 30 cases breast cancer (type Qi-deficiency while toxin flourishing),” Traditional Chinese Medicine Research, no. 7, pp. 28–29, 2007. View at Google Scholar
  45. Z. F. Huang, J. B. Liu, Q. S. Chen, H. Z. Li, Z. J. Zhang, and C. J. Huang, “The effect of Jianpi Xiaoji decoction combined with chemotherapy for the quality of life and immunologic function of advanced breast cancer patients,” Journal of New Chinese Medicine, no. 5, pp. 88–89, 2007. View at Google Scholar
  46. H. Y. Yang, C. L. Tong, and M. Huang, “Clinical observation on Taohongsiwu decoction combined with new adjuvant chemotherapy for breast cancer with stagnation of blood stasis,” Modern Journal of Integrated Traditional Chinese and Western Medicine, no. 10, pp. 1327–1328, 2007. View at Google Scholar
  47. H. Dai, C. L. Zhu, and X. L. Wang, “Tiaoganyangxue decoction combined with NP chemotherapy for 25 cases advanced breast cancer,” Jilin Journal of Traditional Chinese Medicine, no. 4, pp. 33–34, 2004. View at Google Scholar
  48. X. L. Li, Q. Y. Tian, and W. J. Ma, “Clinical observation on Senqifuzheng injection combined with chemotherpay for advanced breast cancer,” Modern Oncology, no. 6, pp. 574–575, 2004. View at Google Scholar
  49. L. Yang and S. Sun, “Clinical research into the treatment of mammary cancer by chemotherapy combined with TCM drugs before operation,” Journal of Hennan University of Chinese Medicine, no. 4, pp. 40–41, 2004. View at Google Scholar
  50. Z. F. Huang, J. S. Wei, Z. Y. Shi, and K. Zhong, “Study of Bazhen decoction and chemotherapy on mammary cancer in metaphase or later period,” Modern Journal of Integr ated Traditional Chinese and Western Medicine, no. 11, pp. 1123–1124, 2003. View at Google Scholar
  51. T. Zhou and F. J. Zhou, “Gonghuanyangxue granule for the Qi-blood-deficiency syndrome of breast cancer after new adjuvant chemotherapy,” Guiding Journal of Traditional Chinese Medicine and Pharmacy, no. 6, pp. 63–65, 2015. View at Google Scholar
  52. L. F. Li and M. Han, “The effect of YIqihuoxue method as an adjuvant therapy for postoperative breast cancer and its impact on patients' quality of life,” Sichuan Jouranl of Traditional Chinese Medicine, no. 3, pp. 119–121, 2015. View at Google Scholar
  53. J. Liu, S. X. Wei, and M. Lu, “The observation of attenuation and synergy of postoperative chemotherapy matching with traditional Chinese drug Tianzhicao capsule in breast cancer,” Medical Journal of West China, no. 5, pp. 896–897, 2011. View at Google Scholar
  54. C. Liu, L. Y. Wu, H. J. Zhao, and N. Yang, “Clinical observation on Rensenyangrong decoction for the Qi-blood-deficiency type of breast cancer which caused by new adjuvant chemotherapy,” The Western Journal of Traditional Chinese Medicine, no. 11, pp. 8–11, 2011. View at Google Scholar
  55. K. H. Chang, R. Brodie, M. A. Choong, K. J. Sweeney, and M. J. Kerin, “Complementary and alternative medicine use in oncology: a questionnaire survey of patients and health care professionals,” BMC Cancer, vol. 11, article 196, 2011. View at Publisher · View at Google Scholar · View at Scopus
  56. S. G. Li, H. Y. Chen, C. S. Ou-Yang et al., “The efficacy of Chinese herbal medicine as an adjunctive therapy for advanced non-small cell lung cancer: a systematic review and meta-analysis,” PLoS ONE, vol. 8, no. 2, Article ID e57604, 2013. View at Publisher · View at Google Scholar · View at Scopus
  57. W. C. S. Cho and H.-Y. Chen, “Clinical efficacy of traditional Chinese medicine as a concomitant therapy for nasopharyngeal carcinoma: a systematic review and meta-analysis,” Cancer Investigation, vol. 27, no. 3, pp. 334–344, 2009. View at Publisher · View at Google Scholar · View at Scopus
  58. W. C. S. Cho and H.-Y. Chen, “Transcatheter arterial chemoembolization combined with or without Chinese herbal therapy for hepatocellular carcinoma: meta-analysis,” Expert Opinion on Investigational Drugs, vol. 18, no. 5, pp. 617–635, 2009. View at Publisher · View at Google Scholar · View at Scopus
  59. J. S. Yates, K. M. Mustian, G. R. Morrow et al., “Prevalence of complementary and alternative medicine use in cancer patients during treatment,” Supportive Care in Cancer, vol. 13, no. 10, pp. 806–811, 2005. View at Publisher · View at Google Scholar · View at Scopus
  60. K. I. Block and M. N. Mead, “Immune system effects of echinacea, ginseng, and astragalus: a review,” Integrative Cancer Therapies, vol. 2, no. 3, pp. 247–267, 2003. View at Publisher · View at Google Scholar · View at Scopus
  61. W. C. S. Cho and K. N. Leung, “In vitro and in vivo immunomodulating and immunorestorative effects of Astragalus membranaceus,” Journal of Ethnopharmacology, vol. 113, no. 1, pp. 132–141, 2007. View at Publisher · View at Google Scholar · View at Scopus
  62. M. McCulloch, C. See, X.-J. Shu et al., “Astragalus-based Chinese herbs and platinum-based chemotherapy for advanced non-small-cell lung cancer: meta-analysis of randomized trials,” Journal of Clinical Oncology, vol. 24, no. 3, pp. 419–430, 2006. View at Publisher · View at Google Scholar · View at Scopus
  63. W. Kim, S.-H. Kim, S. K. Park, and M. S. Chang, “Astragalus membranaceus ameliorates reproductive toxicity induced by cyclophosphamide in male mice,” Phytotherapy Research, vol. 26, no. 9, pp. 1418–1421, 2012. View at Publisher · View at Google Scholar · View at Scopus
  64. A. Flower, C. Witt, J. P. Liu, G. Ulrich-Merzenich, H. Yu, and G. Lewith, “Guidelines for randomised controlled trials investigating Chinese herbal medicine,” Journal of Ethnopharmacology, vol. 140, no. 3, pp. 550–554, 2012. View at Publisher · View at Google Scholar · View at Scopus